HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Zhang Selected Research

nosiheptide

6/2016Enhancing nosiheptide production in Streptomyces actuosus by heterologous expression of haemoprotein from Sinorhizobium meliloti.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Zhang Research Topics

Disease

216Neoplasms (Cancer)
07/2022 - 01/2000
54Infections
06/2022 - 03/2000
49Inflammation (Inflammations)
11/2021 - 01/2000
40Neoplasm Metastasis (Metastasis)
04/2022 - 10/2001
37Breast Neoplasms (Breast Cancer)
11/2021 - 01/2000
29Lung Neoplasms (Lung Cancer)
01/2021 - 02/2000
29Carcinogenesis
12/2019 - 02/2000
28Carcinoma (Carcinomatosis)
01/2022 - 01/2000
25Hypoxia (Hypoxemia)
03/2021 - 12/2001
20Stomach Neoplasms (Stomach Cancer)
04/2022 - 01/2000
20Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 08/2000
19Hepatocellular Carcinoma (Hepatoma)
07/2022 - 01/2000
19Prostatic Neoplasms (Prostate Cancer)
11/2021 - 07/2000
18Asthma (Bronchial Asthma)
04/2022 - 04/2001
18Body Weight (Weight, Body)
11/2021 - 09/2000
17Necrosis
01/2021 - 03/2000
16Wounds and Injuries (Trauma)
04/2022 - 06/2000
16Hypertension (High Blood Pressure)
05/2021 - 01/2000
16Fibrosis (Cirrhosis)
01/2021 - 04/2000
15Adenocarcinoma
02/2021 - 08/2000
14Leukemia
01/2021 - 01/2000
14Melanoma (Melanoma, Malignant)
08/2017 - 11/2001
13Pain (Aches)
12/2020 - 04/2001
12Obesity
12/2021 - 09/2000
12Insulin Resistance
09/2021 - 11/2008
12Type 2 Diabetes Mellitus (MODY)
09/2021 - 11/2008
12Rectal Neoplasms (Rectal Cancer)
08/2021 - 07/2001
12Rheumatoid Arthritis
04/2018 - 10/2000
11Liver Neoplasms (Liver Cancer)
07/2022 - 06/2001
11Osteoarthritis
01/2022 - 08/2001
11Tuberculosis (Tuberculoses)
02/2021 - 12/2000
10Hemorrhage
11/2021 - 10/2010
10Colorectal Neoplasms (Colorectal Cancer)
08/2021 - 09/2001
10Chronic Hepatitis B
08/2021 - 06/2000
10Shock
05/2021 - 06/2000
10Hypersensitivity (Allergy)
08/2016 - 06/2000
9Cataract (Cataracts)
11/2022 - 02/2000
9Hepatitis B
08/2021 - 07/2001
9Diabetes Mellitus
02/2021 - 12/2008
9Adenocarcinoma of Lung
05/2018 - 01/2014
9Lymphatic Metastasis
02/2018 - 04/2003
9Proteinuria
08/2017 - 01/2000
8Pneumonia (Pneumonitis)
09/2021 - 03/2001
8Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 11/2000
8IGA Glomerulonephritis (IGA Nephropathy)
10/2018 - 02/2009
8Atherosclerosis
01/2018 - 04/2000
8Stroke (Strokes)
01/2018 - 03/2001
7Cognitive Dysfunction
11/2022 - 09/2000
7Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 05/2000
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2021 - 05/2001
7Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 06/2000
7Nasopharyngeal Carcinoma
01/2021 - 02/2001
7Myocardial Infarction
12/2020 - 04/2003

Drug/Important Bio-Agent (IBA)

108Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2000
41DNA (Deoxyribonucleic Acid)IBA
09/2021 - 05/2000
40Messenger RNA (mRNA)IBA
06/2022 - 02/2000
30CytokinesIBA
01/2018 - 03/2000
29Biomarkers (Surrogate Marker)IBA
06/2022 - 02/2001
23RNA (Ribonucleic Acid)IBA
01/2022 - 01/2000
22Biological ProductsIBA
12/2020 - 04/2000
21Pharmaceutical PreparationsIBA
07/2022 - 03/2001
20EnzymesIBA
01/2018 - 01/2000
19AntigensIBA
02/2021 - 01/2000
19MicroRNAs (MicroRNA)IBA
01/2020 - 09/2007
18Small Interfering RNA (siRNA)IBA
11/2021 - 09/2009
17Glucose (Dextrose)FDA LinkGeneric
12/2021 - 09/2001
17Oxygen (Dioxygen)IBA
05/2021 - 04/2000
16Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2022 - 12/2000
16Peptides (Polypeptides)IBA
06/2018 - 01/2000
13VaccinesIBA
04/2021 - 09/2000
13Therapeutic UsesIBA
12/2019 - 04/2000
13Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2017 - 03/2000
12Cisplatin (Platino)FDA LinkGeneric
08/2019 - 02/2001
12Indicators and Reagents (Reagents)IBA
04/2018 - 01/2000
11Interleukin-6 (Interleukin 6)IBA
12/2020 - 10/2001
11Paclitaxel (Taxol)FDA LinkGeneric
01/2017 - 07/2000
11AntibodiesIBA
08/2011 - 04/2000
10AllergensIBA
04/2022 - 12/2007
10Immunoglobulin G (IgG)IBA
04/2021 - 10/2001
10ImmunosorbentsIBA
01/2018 - 04/2000
10Phosphotransferases (Kinase)IBA
01/2017 - 12/2000
9LipidsIBA
05/2022 - 06/2000
9ErbB Receptors (EGF Receptor)IBA
02/2022 - 07/2000
9Amino AcidsFDA Link
11/2021 - 05/2000
9Insulin (Novolin)FDA Link
05/2021 - 09/2011
9Matrix Metalloproteinases (MMPs)IBA
01/2021 - 01/2000
9ParaffinIBA
08/2017 - 01/2000
8Estrogens (Estrogen)FDA Link
01/2020 - 08/2000
8Cadherins (E-Cadherin)IBA
06/2016 - 10/2001
7Blood Glucose (Blood Sugar)IBA
01/2022 - 09/2001
7CateninsIBA
01/2021 - 05/2014
7Hemoglobins (Hemoglobin)IBA
11/2020 - 10/2000

Therapy/Procedure

104Therapeutics
09/2022 - 02/2000
37Drug Therapy (Chemotherapy)
02/2021 - 01/2000
23Radiotherapy
01/2021 - 10/2000
13Aftercare (After-Treatment)
06/2021 - 12/2000
12Neoadjuvant Therapy
07/2022 - 02/2015
11Transplantation
09/2021 - 05/2001
9Ligation
12/2020 - 12/2001
7Hematopoietic Stem Cell Transplantation
10/2020 - 06/2009